dc.contributor.author | Eggleton, P | en_GB |
dc.contributor.author | Bremer, E | en_GB |
dc.contributor.author | Tarr, J.M. | en_GB |
dc.contributor.author | de Bruyn, M | en_GB |
dc.contributor.author | Helfrich, W | en_GB |
dc.contributor.author | Kendall, A | en_GB |
dc.contributor.author | Haigh, Richard | en_GB |
dc.contributor.author | Viner, N.J. | en_GB |
dc.contributor.author | Winyard, Paul G. | en_GB |
dc.date.accessioned | 2012-12-14T14:13:20Z | en_GB |
dc.date.accessioned | 2013-03-20T17:10:43Z | |
dc.date.issued | 2011-12-15 | en_GB |
dc.description.abstract | Rheumatoid arthritis (RA) is considered a T cell driven autoimmune disease, therefore, the ability of B cell depleting biologics, e.g., anti-CD20 antibodies, to alleviate RA is unclear. This study examined the proportions of IL-17-secreting lymphocytes in the blood of healthy subjects and RA patients and determined if Th17 cells belong to a CD20+ subset of T cells. | en_GB |
dc.identifier.citation | Vol. 13, Issue 6, article R208 | en_GB |
dc.identifier.doi | 10.1186/ar3541 | en_GB |
dc.identifier.uri | http://hdl.handle.net/10036/4086 | en_GB |
dc.publisher | BMC | |
dc.title | Frequency of Th17 CD20+ cells in the peripheral blood of rheumatoid arthritis patients is higher compared to healthy subjects | en_GB |
dc.type | Article | |
dc.date.available | 2012-12-14T14:13:20Z | en_GB |
dc.date.available | 2013-03-20T17:10:43Z | |
exeter.place-of-publication | England | en_GB |
dc.identifier.journal | Arthritis Research and Therapy | en_GB |